Skip to main content
SpringerLink
Log in

The Use of Psychotropic Drugs in the Treatment of Cancer Pain

  • Conference paper
Pain in the Cancer Patient

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 89))

Abstract

Psychotropic drugs — especially antidepressants and neuroleptics — have become an important element in the treatment of cancer pain. Soon after the introduction of neuroleptics in 1951/52 and antidepressants in 1957 in psychiatry, the first publications appeared reporting their beneficial analgesic effect. Later publications emphasized that psychotropic drugs may potentiate the effects of analgesics and help to reduce their use.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adjan M (1970) Zur therapeutischen Beeinflussung des Schmerzsymptoms bei unheilbaren Tumorkranken. Ther Ggw 109: 1620–1627

    PubMed  Google Scholar 

  • Barjou B (1971) Etude du Tofranil sur les douleurs en chirurgie. Revue Med Tours 6: 473–482

    Google Scholar 

  • Beaumont G (1976) The use of psychotropic drugs in other painful conditions. J Int Med Res [Suppl2] 4: 56–57

    PubMed  CAS  Google Scholar 

  • Bernard PhA, Scheurer H (1972) Action de la clorimipramine (Anafranil) sur da douleur des cancers en pathologie cervico-faciale. J Fr Otorhinolaryngol 21: 723–729

    CAS  Google Scholar 

  • Bloomfield S, Simard-Savoie S, Bernier J, Tretault L (1964) Comparative analgesic activity of levopromazine and morphine in patients with chronic pain. Can Med Assoc J 90: 1156–1159

    PubMed  CAS  Google Scholar 

  • Clay GS, Brougham LR (1975) Haloperidol binding to an opiate receptor site. Biochem Pharmacol 42: 1363–1367

    Article  Google Scholar 

  • Creese J, Feinberg AP, Snyder SH (1976) Butyrophenone influences on opiate receptor. Eur J Pharmacol 36: 231–235

    Article  PubMed  CAS  Google Scholar 

  • Daxelmüller L (1966) Zur Therapie schwerer Schmerzzustände mit Tofranil. Med Welt 43: 2339–2340

    PubMed  Google Scholar 

  • Deutschmann W (1971) Tofranil in der Schmerzbehandlung der Krebskranken. Med Welt 22: 1346–1347

    Google Scholar 

  • Dilhuydy JM, Miguel Y, Oyon J (1979) Etude en double insu du tiapride dans les algies en carcinologie. Sem Hop Paris 55: 2020–2021

    PubMed  CAS  Google Scholar 

  • Flohé L, Friderichs E (1978) Alte Probleme und neue Aspekte in der Analgesieforschung. Drug Res 28: 99–106

    Google Scholar 

  • Gebhart KH, Beller J, Nischk R (1969) Behandlung des Karzinomschmerzes mit Chlorimipramin (Anafranil). Med Klin 64: 751–756

    Google Scholar 

  • Gennari C, Nami R, Pizzuti M, D’Ascenzo G, Bianchini C (1981) Effects du tiapride en perfusion sur le taux plasmatique de betaendorphine, prolactine et dopamine chez des patients souffrant d’algies cancereuses. Sem Hop Paris 57: 795–800

    PubMed  CAS  Google Scholar 

  • Gram LF (1974) Influence of neuroleptics and benzodiazepines on metabolism of tricyclic antidepressants in man. Am J Psychiatry 131: 863

    PubMed  CAS  Google Scholar 

  • Karkalas Y, Lal H (1973) A comparison of haloperidol with methadone in blocking heroin withdrawal symptoms. Int Pharmacopsychiatry 8: 248–251

    PubMed  CAS  Google Scholar 

  • Kocher R (1969) Zur Behandlung schwerer Schmerzzustände mit einer Kombination von Tofranil (Imipramin) und Nozinan (Laevopromazin). Praxis 57: 1459–1464

    Google Scholar 

  • Kocher R (1976) The use of psychotropic drugs in the treatment of chronic, severe pains. In: Bonica JJ, Albe-Fessard D (eds) Advances in pain research and therapy, vol 1. Raven, New York, pp 285–289

    Google Scholar 

  • Kocher R (1979) The use of psychotropic drugs in the treatment of cancer pain. In: Bonica JJ, Ventafridda V (eds) Advances in pain research and therapy, vol 2. Raven, New York, pp 579–582

    Google Scholar 

  • Lepille D, Bastit Ph (1979) Essai thérapeutique dans les algies néoplasiques. Sem Hop Paris 55: 791–795

    PubMed  CAS  Google Scholar 

  • Linke H (1963) Die Entpersönlichung des Schmerzes durch Phenothiazinderivate. Ther Berichte 35: 94–99

    Google Scholar 

  • Maltbie AA, Cavenar O, Sullivan JL, Hammet EB (1979) Analgesia and haloperidol: a hypothesis. J Clin Psychiatry 40: 323–326

    PubMed  CAS  Google Scholar 

  • Mayer DJ, Price DP (1976) Central nervous system mechanism of analgesia. Pain 2: 379–404

    Article  PubMed  CAS  Google Scholar 

  • Merskey H, Hester RA (1972) The treatment of chronic pain with psychotropic drugs. Postgrad Med J 48: 494–598

    Google Scholar 

  • Mönkemeier D, Steffen U (1970) Zur Behandlung mit Imipramin bei Krebserkrankungen. Med Klin 65: 213–215

    PubMed  Google Scholar 

  • Pessey JJ, Lacomme Y (1980) Tiapride use in neoplasic algia. Sem Hop Paris 56: 351–353

    PubMed  CAS  Google Scholar 

  • Put TR (1974) Traitement des douleurs rebelles à l’aide du flupenthixol et du mélitracène. Ars Medici 29: 1401–1413

    Google Scholar 

  • Simon EJ (1976) The opiate receptors. Neurochem Res 1: 3–28

    Article  CAS  Google Scholar 

  • Spencer PSJ (1976) Some aspects of pharmacology of analgesia. J Int Med Res 4: 1–14

    PubMed  CAS  Google Scholar 

  • Spencer PSJ, Lee RL, Sewell RDE (1979) Centrally-acting analgesics. A brief review of opiates and psychotropic drugs. Pharmaceut Med 1: 6–20

    Google Scholar 

  • Takagi H (1980) The nucleus reticularis paragiganto-cellularis as a site of analgesic-action of morphine and enkephalin. Trends Pharmacol Sci 1: 182–184

    Article  CAS  Google Scholar 

  • Taub A, Collins WF (1974) Observations on the treatment on denervation dysaesthesia with psychotropic drugs: postherpetic neuralgia, anaesthesia, dolorosa, peripheral neuropathy. Adv Neurol 4: 309–315

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Psychiatrische Universitätsklinik, Wilhelm-Klein-Strasse 27, 4025, Basel, Switzerland

    R. Kocher

Authors
  1. R. Kocher
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. II. Physiologisches Institut, Universität Heidelberg, Im Neuenheimer Feld 326, 6900, Heidelberg 1, Germany

    Manfred Zimmermann

  2. Klinik für Thoraxerkrankungen der Landesversicherungsanstalt Baden, Krankenhaus Rohrbach, Amalienstrasse 5, 6900, Heidelberg 1, Germany

    Peter Drings

  3. Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280, 6900, Heidelberg 1, Germany

    Gustav Wagner

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Springer-Verlag Berlin · Heidelberg

About this paper

Cite this paper

Kocher, R. (1984). The Use of Psychotropic Drugs in the Treatment of Cancer Pain. In: Zimmermann, M., Drings, P., Wagner, G. (eds) Pain in the Cancer Patient. Recent Results in Cancer Research, vol 89. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82028-1_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-82028-1_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-82030-4

  • Online ISBN: 978-3-642-82028-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation